{"filing":{"accession_number":"0001213900-26-074980","cik":"0001872529","ticker":"MDXH","company_name":"MDxHealth SA","form":"6-K","filing_date":"2026-07-02","report_date":null,"primary_document":"ea0296595-6k_mdxhealth.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1872529/000121390026074980/ea0296595-6k_mdxhealth.htm"},"events":[{"id":15845,"run_id":14135,"accession_number":"0001213900-26-074980","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"MDxHealth received a Nasdaq notification dated June 30, 2026, that it has failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days (until December 28, 2026) to regain compliance or faces potential delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting investor assessment of the company's continued listing status.","company_name":"MDxHealth SA","ticker":"MDXH","filing_date":"2026-07-02","form":"6-K","submitted_at":null,"items":[{"id":13748,"accession_number":"0001213900-26-074980","item_number":"EX-99.1","item_title":"ea029659501ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"MDxHealth received a Nasdaq notification dated June 30, 2026, that it has failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days (until December 28, 2026) to regain compliance or faces potential delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting investor assessment of the company's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:17:43.091977+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13748,"accession_number":"0001213900-26-074980","item_number":"EX-99.1","item_title":"ea029659501ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"MDxHealth received a Nasdaq notification dated June 30, 2026, that it has failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days (until December 28, 2026) to regain compliance or faces potential delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting investor assessment of the company's continued listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:17:43.091977+00:00","company_name":"MDxHealth SA","ticker":"MDXH","filing_date":"2026-07-02"}]}